[go: up one dir, main page]

FR3095591B1 - Combination of an extract of Uncaria tomentosa liana and an extract of oat seedlings to modulate the pathways of nociception - Google Patents

Combination of an extract of Uncaria tomentosa liana and an extract of oat seedlings to modulate the pathways of nociception Download PDF

Info

Publication number
FR3095591B1
FR3095591B1 FR1904629A FR1904629A FR3095591B1 FR 3095591 B1 FR3095591 B1 FR 3095591B1 FR 1904629 A FR1904629 A FR 1904629A FR 1904629 A FR1904629 A FR 1904629A FR 3095591 B1 FR3095591 B1 FR 3095591B1
Authority
FR
France
Prior art keywords
extract
nociception
pathways
liana
modulate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1904629A
Other languages
French (fr)
Other versions
FR3095591A1 (en
Inventor
Fabrice Lestienne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Dermo Cosmetique SA
Original Assignee
Pierre Fabre Dermo Cosmetique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA
Priority to FR1904629A priority Critical patent/FR3095591B1/en
Publication of FR3095591A1 publication Critical patent/FR3095591A1/en
Application granted granted Critical
Publication of FR3095591B1 publication Critical patent/FR3095591B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L’invention concerne une nouvelle association d’un extrait de liane uncaria tomentosa et d’un extrait de plantule d’avoine et ses utilisations dans l’inflammation neurogène cutanée, et dans la modulation des voies de la nociception, notamment dues aux dermatoses inflammatoires.The invention relates to a novel combination of an extract of liana uncaria tomentosa and an extract of oat seedlings and its uses in neurogenic skin inflammation, and in the modulation of nociception pathways, in particular due to inflammatory dermatoses. .

FR1904629A 2019-05-02 2019-05-02 Combination of an extract of Uncaria tomentosa liana and an extract of oat seedlings to modulate the pathways of nociception Expired - Fee Related FR3095591B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1904629A FR3095591B1 (en) 2019-05-02 2019-05-02 Combination of an extract of Uncaria tomentosa liana and an extract of oat seedlings to modulate the pathways of nociception

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1904629 2019-05-02
FR1904629A FR3095591B1 (en) 2019-05-02 2019-05-02 Combination of an extract of Uncaria tomentosa liana and an extract of oat seedlings to modulate the pathways of nociception

Publications (2)

Publication Number Publication Date
FR3095591A1 FR3095591A1 (en) 2020-11-06
FR3095591B1 true FR3095591B1 (en) 2021-11-19

Family

ID=67999786

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1904629A Expired - Fee Related FR3095591B1 (en) 2019-05-02 2019-05-02 Combination of an extract of Uncaria tomentosa liana and an extract of oat seedlings to modulate the pathways of nociception

Country Status (1)

Country Link
FR (1) FR3095591B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3139990A1 (en) * 2022-09-22 2024-03-29 Pierre Fabre Dermo-Cosmetique Cosmetic or dermatological compositions for balancing the skin microbiota

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1552844A1 (en) * 2004-01-07 2005-07-13 Leendert Taal Botanical extract composition
FR2938439B1 (en) 2008-11-14 2013-03-01 Fabre Pierre Dermo Cosmetique EXTRACT OF AERIAL PARTS OF OATS HARVESTED BEFORE EPIAISON
CN111246847A (en) * 2017-08-25 2020-06-05 聪明智商股份有限公司 Functional chewing gum containing phytonutrients and adaptogen herbs

Also Published As

Publication number Publication date
FR3095591A1 (en) 2020-11-06

Similar Documents

Publication Publication Date Title
MA38341A1 (en) Methylation modification enzyme modulators, compositions and uses thereof
CR20210592A (en) MODULATORS OF THE INTEGRATED STRESS PATHWAY
MX2021013193A (en) Substituted cyclolakyls as modulators of the integrated stress pathway.
BR112021024108A2 (en) Tead inhibitors and uses thereof
MX2023009561A (en) Prodrug modulators of the integrated stress pathway.
PH12020550523A1 (en) Modulators of the integrated stress pathway
PH12020550524A1 (en) Modulators of the integrated stress pathway
MA42164B1 (en) Biheteroaryl compounds and their uses
MA39001A1 (en) Alkyl-amide substituted pyridyl compounds useful as modulators of IL-12, IL-23 and / or responses to IFN?
EA201790806A1 (en) IMMUNOREGULATING AGENTS
AU2017260367A1 (en) Modulators of the integrated stress pathway
JOP20210115A1 (en) Compositions and methods of modulating short-chain dehydrogenase activity
EA201790998A1 (en) IMMUNOREGULATING AGENTS
EP4219718A3 (en) Compositions and methods for modulating complement factor b expression
EA201290748A1 (en) DERIVATIVES OF 4- (N-AZACYCLOALKYL) ANILIDES AS A POTASSIUM CHANNEL MODULATORS
AU2017260374A1 (en) Modulators of the integrated stress pathway
FR3069450B1 (en) USE OF DIALKYL CARBONATE AS AN EXTRACTION SOLVENT
MA47736B1 (en) Pyrimidopyrimidinones useful as wee-1 kinase inhibitors
EA201491385A1 (en) METALLIC ENZYME INHIBITING COMPOUNDS
EP4309732A3 (en) Modulators of pcsk9 expression
MX2022008479A (en) Low-dose brimonidine combinations and uses thereof.
EA202090513A1 (en) AGENTS MODULATING THE FUNCTIONS OF BETA-CATENIN AND RELATED METHODS
EA201892438A1 (en) 6-AMINOPIRIDIN-3-ILHIAZOLES AS RORγt MODULATORS
WO2021089768A3 (en) Treatment and prevention of a neurodegenerative disorder
CL2024003023A1 (en) lrrk2 inhibitors.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20201106

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

ST Notification of lapse

Effective date: 20240105